z-logo
open-access-imgOpen Access
New advances in the understanding of the in-source decay fragmentation of peptides in MALDI-TOF-MS
Author(s) -
Kevin Demeure,
Valérie Gabelica,
Edwin De Pauw
Publication year - 2010
Publication title -
journal of the american society for mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 127
eISSN - 1879-1123
pISSN - 1044-0305
DOI - 10.1016/j.jasms.2010.07.009
Subject(s) - chemistry , fragmentation (computing) , ion , mass spectrometry , ionization , matrix assisted laser desorption/ionization , peptide , matrix (chemical analysis) , desorption , analytical chemistry (journal) , chromatography , biochemistry , organic chemistry , adsorption , computer science , operating system
In-source decay (ISD) is a rapid fragmentation occurring in the matrix-assisted laser desorption/ionization (MALDI) source before the ion extraction. Despite the increasing interest for peptides de novo sequencing by ISD, the influence of the matrix and of the peptide itself is not yet fully understood. Here we compare matrices with high ISD efficiencies to gain deeper insight in the ISD fragmentation process(es). The major ISD fragments are the c- and z-ions, but other types of fragments are also observed, and their origin is studied here. Two main pathways lead to fragmentation in the source: a radical-induced pathway that leads to c-, z-, w-, and d-ions, and a thermally activated pathway that leads to y-, b-, and a-ions. A detailed analysis of the ISD spectra of selected peptides revealed that (1) the extents of the two in-source pathways are differently favored depending on the matrix used, that (2) the presence of a positive/negative charge on the radical-induced fragments is necessary for their observation in positive/negative mode, respectively, and that (3), for a same peptide, the patterns of the different types of fragments differ according to the matrix used.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here